| 引用本文：谭清立, 伍明根.药品集中带量采购背景下中小药企竞争战略研究——基于波特五力模型和AHP-SWOT分析[J].中国卫生政策研究,2022,15(8):62-67 |
|
| 药品集中带量采购背景下中小药企竞争战略研究——基于波特五力模型和AHP-SWOT分析 |
| 投稿时间：2022-07-19 修订日期：2022-08-02 PDF全文浏览 HTML全文浏览 |
| 谭清立1,2, 伍明根1 |
1. 广东药科大学医药商学院 广东中山 528453;
2. 广东省药品监管科学研究基地 广东广州 510006 |
| 摘要:随着药品集中带量采购的常态化开展，医药行业市场格局发生重大改变。作为制药行业中的弱势企业，中小药企面临的困境不容忽视。中小药企具有创新意愿强、结构精简、转型容易等优势，也有资金少、人才缺乏等劣势。文章首先阐述中小药企发展现状，然后运用波特五力模型和AHP-SWOT分析法分别从外部环境和内部环境对中小药企的竞争战略进行分析，得出中小药企最优竞争战略为扭转型战略。最后，根据研究结果提出相应建议，以应对带量采购背景下中小药企所面临的困境，探寻中小药企发展之路。 |
| 关键词:集中带量采购 中小药企 AHP-SWOT 波特五力模型 |
| 基金项目:广东软科学计划面上项目(2019A101002068) |
|
| Research on the competition strategies of small and medium pharmaceutical enterprises under the background of centralized volume-based drug procurement policy: Based on Porter's Five Forces Model and AHP-SWOT |
| TAN Qing-li1,2, WU Ming-gen1 |
1. School of Medical Business, Guangdong Pharmaceutical University, Zhongshan Guangdong 528453, China;
2. Guangdong Research Base for Drug Regulatory Science, Guangzhou Guangdong 510006, China |
| Abstract:With the general implementation of centralized volume-based drug procurement policy, the structure of the pharmaceutical industry market has changed tremendously. As a vulnerable group in the pharmaceutical industry, the difficulties faced by small and medium pharmaceutical enterprises shall not be ignored. Small and medium pharmaceutical enterprises have the advantages of strong willingness of innovation, simplified structure and low difficulty in transformation, but also have disadvantages such as lack of funds and talents. This work first articulated the current development situation of small and medium pharmaceutical enterprises, and then analyzed the competition strategies of small and medium pharmaceutical enterprises both from the external and internal environments by using Porter's Five Forces Model and AHP-SWOT, which concluded the optimal strategy to be WO strategy. Lastly, suggestions were raised according to the research results to deal with the difficulties faced by small and medium pharmaceutical enterprises under the background of centralized volume-based drug procurement and to explore the route of development for small and medium pharmaceutical enterprises. |
| Key words:Centralized volume-based procurement Small and medium pharmaceutical enterprise AHP-SWOT Porter's Five Forces Model |
| 摘要点击次数: 1468 全文下载次数: 542 |
|
|
